All Type of News
200 products approved by bioequivalent test this year, decreased by 29% year-on-year
The number of pharmaceutical products newly approved by bioequivalent test this year was 200 products, decreased by 29% compared to the same period of the last year.
According to the Ministry of Food and Drug Safety,...
KPBMA, “It is necessary to install presidential control tower”
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) made a request to 19th President Jae-In Moon for ‘Installation of the Presidential Control Tower,’ which will create a valuable result called ‘n...
Kangstem Biotech selected by ‘F1000Prime’ for its publication about rheumatoid arthritisKangstem Biotech announced on the 8th that a paper about ‘Furestem-RA,’a rheumatoid arthritis stem cell treatment being developed by the company, was selected as an excellent pa...
|
Daewoong, “Nabota counterfeits were exposed by investigative agency”Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced a group of people who made counterfeit ‘Nabota’ products was arrested and confirmed distribution of these products to China....
|
Pfizer Pharmaceuticals Korea carry out patent support program of ‘Ibrance,’ breast cancer treatmentPfizer Pharmaceuticals Korea will start a patient support program for ‘Ibrance(generic name: palbociclib),’ a breast cancer therapy.
According to the company, it internally had...
|
New administration raises expectations with prohibition of corporate pharmacies and reduction of fees for credit card readers
The Minjoo Party Candidate Jae-In Moon was elected with a 41.1% percent of popular support at the 19th Presidential Election on the 9th of May.
After visiting the Seoul National Cemetery and making the inauguration s...
Pharmaceutical & biotechnology industry bounces up with presidency of Jae-In Moon
The election of Presidential Candidate Jae-In Moon as the 19th president of Korea is expected to bring positive impacts even to the pharmaceutical industry.
The expectation is based on the debates related to health a...
Jeil enters hyaluronic acid filler market
Jeil Pharm(CEO/President Suk-Jae Sung) launched ‘Revanesse’ and ‘ReDexis,’ high-purity hyaluronic acid(HA) wrinkle fillers applied with the ‘Thixofix Cross-linking Technology,’ a patented technology developed by Canad...
Sillajen’s co-development agreement of renal cancer treatment with U.S. RegeneronPharmaceuticals
Sillajen(CEO Eun-Sang Moon) announced in a joint statement on the 8th that it signed a co-research agreement of renal cell carcinoma(renal cancer) treatment development with U.S. ‘RegeneronPharmaceuticals.’
Under the...
Plan to nurture Advanced Medical Care Complex as global hub to lead Industry 4.0
The Ministry of Health and Welfare(MOHW) announced on the 8th that it decided the 3rd Comprehensive Plan(2017-2019) for the Advanced Medical Care Complex, which will be established to have services, such as efficacy a...
